PI3K pathway mutation predicts an activated immune microenvironment and better immunotherapeutic efficacy in head and neck squamous cell carcinoma

被引：0
作者：
Libo Wang
Kejun Chen
Siyuan Weng
Hui Xu
Yuqing Ren
Quan Cheng
Peng Luo
Jian Zhang
Zaoqu Liu
Xinwei Han
机构：
[1] The First Affiliated Hospital of Zhengzhou University,Department of Interventional Radiology
[2] The First Affiliated Hospital of Zhengzhou University,Department of Hepatobiliary and Pancreatic Surgery
[3] The First Affiliated Hospital of Zhengzhou University,Department of Thyroid Surgery
[4] Interventional Institute of Zhengzhou University,Department of Respiratory and Critical Care Medicine
[5] Interventional Treatment and Clinical Research Center of Henan Province,Department of Neurosurgery, Xiangya Hospital
[6] The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Zhujiang Hospital
[7] Central South University,undefined
[8] Southern Medical University,undefined
来源：
World Journal of Surgical Oncology | / 21卷
关键词：
Head and neck squamous cell carcinoma; PI3K pathway mutation; Immunotherapy; Immune environment; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 267 条
[1]  
Leemans CR(2018)The molecular landscape of head and neck cancer Nat Rev Cancer 18 269-282
[2]  
Snijders PJF(2019)Real-world systemic therapy treatment patterns for squamous cell carcinoma of the head and neck in Canada Curr Oncol 26 e167-ee74
[3]  
Brakenhoff RH(2002)Therapeutic outcome and side-effects after radiotherapy, chemotherapy and/or hyperthermia treatment of head and neck tumour xenografts Eur J Cancer 38 594-601
[4]  
Byrne K(2021)The burden of head and neck cancer in the United States, 1990 - 2017 J Oral Maxillofac Surg 79 2162-2170
[5]  
Hallworth P(2013)Signaling by the phosphoinositide 3-kinase family in immune cells Annu Rev Immunol 31 675-704
[6]  
Monfared AAT(2003)The role of PI3K in immune cells Nat Immunol 4 313-319
[7]  
Moshyk A(2018)Oncogenic pathways that affect antitumor immune response and immune checkpoint blockade therapy Pharmacol Ther 18 176-184
[8]  
Shaw JW(2017)AR Signaling and the PI3K pathway in prostate cancer Cancers (Basel) 9 34-524
[9]  
Ressel A(2016)PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment Cancer Metastasis Rev 35 515-30
[10]  
Schmitt O(2015)The role of the PI3K pathway in colorectal cancer Crit Rev Oncol Hematol 94 18-1867
12345678910